Acyclovir Tablet
Product Images NDC 75834-123

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Acyclovir (NDC 75834-123). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nivagen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Acyclovir 01)

FDA Label Image

Principal Display Panel (400 mg Tablet Bottle Label)

Principal Display Panel (400 mg Tablet Bottle Label)
NDC 75834-122-01 Acyclovir Tablets, USP containing 400 mg per tablet comes in a pack of 100 Tablets. It is advisable to store it in a tight light-resistant container at 15°-25°C (59°to 77°F) and ensure it is protected from light and moisture. Dosage and administration should be as seen in the package insert. It is manufactured by Cadila Pharmaceuticals Ltd in India, while it is wholly owned and distributed by Nivagen Pharmaceuticals, Inc, Sacramento, CA 95827, and can be reached on 1-877-977-0687. Mig Lic No is 6/1500.*
FDA Label Image

Principal Display Panel (800 mg Tablet Bottle Label)

Principal Display Panel (800 mg Tablet Bottle Label)
NDC 75834-123-01 is a medication called Acyclovir, which comes in 100 tablets with each tablet containing 800mg of acyclovir USP. The medication is manufactured by Cadila Pharmaceuticals Ltd. and distributed by Nivagen Pharmaceuticals, Inc. The usual dosage recommendations are provided inside the package. It is advised to store the medication at 15° to 25°C (59° to 77°F) and protect from light and moisture. The product comes with a manufacturing license number G/1500 and was issued on 08/2016.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.